Symptom relief for worsening heart failure
from By Dorothy L. Tengler
Heart failure is a growing problem. More than 20 million people worldwide are affected by heart failure, including more than 5 million in the United States alone. TRUE-AHF was a Phase III, multicenter, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the efficacy and safety of ularitide as an intravenous infusion in addition to conventional therapy in patients suffering from acute cardiac failure.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063